Chrome Extension
WeChat Mini Program
Use on ChatGLM
VIPCreated with Sketch.

GS-005 Mrecist Outcomes in EMERALD-1: a Phase 3, Randomized, Placebo-Controlled Study of Transarterial Chemoembolization Plus Durvalumab With/without Bevacizumab in Participants with Embolization-Eligible Hepatocellular Carcinoma

Bruno Sangro,Masatoshi Kudo,Joseph Erinjeri,Shukui Qin,Zhenggang Ren,Stephen Chan,Yasuaki Arai,Jeong Heo, Ahn Mai, Jose Escobar,Yamil Alonso Lopez Chuken,Jung-Hwan Yoon,Won Young Tak,Tanita Suttichaimongkol,Mohamed Bouattour,Shi-Ming Lin,Magdalena Żotkiewicz,Sajid Ali,Gordon Cohen,Riccardo Lencioni

Journal of Hepatology（2024）

Cited 0|Views5
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined